Oramed Pharmaceuticals Inc (ORMP)
2.37
+0.04
(+1.72%)
USD |
NASDAQ |
Apr 23, 16:00
2.40
+0.03
(+1.27%)
After-Hours: 20:00
Oramed Pharmaceuticals Price: 2.37 for April 23, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Apr 23, 2024 | 2.34 | 2.43 | 2.34 | 2.37 | 30132.00 |
Apr 22, 2024 | 2.27 | 2.40 | 2.25 | 2.33 | 59529.00 |
Apr 19, 2024 | 2.19 | 2.30 | 2.182 | 2.27 | 113681.0 |
Apr 18, 2024 | 2.34 | 2.37 | 2.14 | 2.20 | 240869.0 |
Apr 17, 2024 | 2.40 | 2.410 | 2.27 | 2.33 | 149862.0 |
Apr 16, 2024 | 2.44 | 2.45 | 2.33 | 2.40 | 116858.0 |
Apr 15, 2024 | 2.57 | 2.57 | 2.40 | 2.42 | 152601.0 |
Apr 12, 2024 | 2.59 | 2.64 | 2.50 | 2.52 | 72512.00 |
Apr 11, 2024 | 2.66 | 2.690 | 2.57 | 2.58 | 108919.0 |
Apr 10, 2024 | 2.67 | 2.73 | 2.643 | 2.66 | 63591.00 |
Apr 09, 2024 | 2.73 | 2.81 | 2.66 | 2.69 | 126500.0 |
Apr 08, 2024 | 2.64 | 2.80 | 2.64 | 2.77 | 84270.00 |
Apr 05, 2024 | 2.60 | 2.69 | 2.51 | 2.61 | 174544.0 |
Apr 04, 2024 | 2.74 | 2.80 | 2.61 | 2.61 | 177745.0 |
Apr 03, 2024 | 2.78 | 2.795 | 2.72 | 2.75 | 97920.00 |
Apr 02, 2024 | 2.80 | 2.825 | 2.725 | 2.80 | 81209.00 |
Apr 01, 2024 | 2.95 | 2.95 | 2.78 | 2.83 | 112963.0 |
Mar 28, 2024 | 2.83 | 3.14 | 2.78 | 2.92 | 211195.0 |
Mar 27, 2024 | 2.70 | 2.84 | 2.66 | 2.82 | 160613.0 |
Mar 26, 2024 | 2.76 | 2.83 | 2.69 | 2.72 | 88737.00 |
Mar 25, 2024 | 2.89 | 2.89 | 2.71 | 2.76 | 167630.0 |
Mar 22, 2024 | 2.80 | 2.93 | 2.78 | 2.91 | 68859.00 |
Mar 21, 2024 | 2.93 | 3.03 | 2.79 | 2.80 | 141380.0 |
Mar 20, 2024 | 2.90 | 2.99 | 2.82 | 2.96 | 137758.0 |
Mar 19, 2024 | 2.78 | 2.91 | 2.78 | 2.83 | 80842.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.71
Minimum
Nov 01 2023
29.75
Maximum
Nov 08 2021
6.427
Average
3.93
Median
Jul 27 2020
Price Benchmarks
Inogen Inc | 6.90 |
Petros Pharmaceuticals Inc | 0.6801 |
DIH Holding US Inc | 1.31 |
NovaBay Pharmaceuticals Inc | 0.077 |
Palatin Technologies Inc | 1.75 |
Price Related Metrics
PE Ratio | 17.14 |
PS Ratio | 36.01 |
Price to Book Value | 0.5936 |
Earnings Yield | 5.83% |
Market Cap | 97.25M |